Last10K.com

Miromatrix Medical Inc. (MIRO) SEC Filing 8-K Material Event for the period ending Tuesday, March 1, 2022

Miromatrix Medical Inc.

CIK: 1527096 Ticker: MIRO

View differences made from one to another to evaluate Miromatrix Medical Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Miromatrix Medical Inc..

Continue

Assess how Miromatrix Medical Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Miromatrix Medical Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Miromatrix Medical Inc. provided additional information to their SEC Filing as exhibits

Ticker: MIRO
CIK: 1527096
Form Type: 8-K Corporate News
Accession Number: 0001558370-22-002614
Submitted to the SEC: Tue Mar 01 2022 5:15:22 PM EST
Accepted by the SEC: Tue Mar 01 2022
Period: Tuesday, March 1, 2022
Industry: Biological Products No Disgnostic Substances
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/miro/0001558370-22-002614.htm